Annual CFI
$104.13 M
+$149.62 M+328.91%
December 31, 2023
Summary
- As of February 8, 2025, RAPT annual cash flow from investing activities is $104.13 million, with the most recent change of +$149.62 million (+328.91%) on December 31, 2023.
- During the last 3 years, RAPT annual CFI has risen by +$191.57 million (+219.10%).
- RAPT annual CFI is now at all-time high.
Performance
RAPT Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
$18.45 M
-$768.00 K-4.00%
September 30, 2024
Summary
- As of February 8, 2025, RAPT quarterly cash flow from investing activities is $18.45 million, with the most recent change of -$768.00 thousand (-4.00%) on September 30, 2024.
- Over the past year, RAPT quarterly CFI has dropped by -$7.30 million (-28.37%).
- RAPT quarterly CFI is now -43.14% below its all-time high of $32.44 million, reached on June 30, 2023.
Performance
RAPT Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
$74.18 M
-$7.30 M-8.96%
September 30, 2024
Summary
- As of February 8, 2025, RAPT TTM cash flow from investing activities is $74.18 million, with the most recent change of -$7.30 million (-8.96%) on September 30, 2024.
- Over the past year, RAPT TTM CFI has increased by +$31.96 million (+75.69%).
- RAPT TTM CFI is now -28.76% below its all-time high of $104.13 million, reached on December 31, 2023.
Performance
RAPT TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
RAPT Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +328.9% | -28.4% | +75.7% |
| 3 y3 years | +219.1% | +230.1% | +248.5% |
| 5 y5 years | +3075.2% | +10000.0% | +8900.0% |
RAPT Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +228.0% | -43.1% | +144.7% | -28.8% | +191.2% |
| 5 y | 5-year | at high | +219.1% | -43.1% | +129.0% | -28.8% | +171.3% |
| alltime | all time | at high | +219.1% | -43.1% | +129.0% | -28.8% | +171.3% |
RAPT Therapeutics Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $18.45 M(-4.0%) | $74.18 M(-9.0%) |
| Jun 2024 | - | $19.21 M(+20.9%) | $81.49 M(-14.0%) |
| Mar 2024 | - | $15.89 M(-23.0%) | $94.71 M(-9.0%) |
| Dec 2023 | $104.13 M(-328.9%) | $20.64 M(-19.8%) | $104.13 M(+146.6%) |
| Sep 2023 | - | $25.75 M(-20.6%) | $42.22 M(-3856.6%) |
| Jun 2023 | - | $32.44 M(+28.2%) | -$1.12 M(-97.4%) |
| Mar 2023 | - | $25.31 M(-161.3%) | -$44.02 M(-3.2%) |
| Dec 2022 | -$45.49 M(-44.1%) | -$41.27 M(+134.5%) | -$45.49 M(+126.2%) |
| Sep 2022 | - | -$17.60 M(+68.3%) | -$20.11 M(+20.5%) |
| Jun 2022 | - | -$10.46 M(-143.9%) | -$16.69 M(-76.1%) |
| Mar 2022 | - | $23.84 M(-250.0%) | -$69.92 M(-14.0%) |
| Dec 2021 | -$81.35 M | -$15.89 M(+12.1%) | -$81.35 M(+62.8%) |
| Sep 2021 | - | -$14.17 M(-77.7%) | -$49.96 M(+43.9%) |
| Jun 2021 | - | -$63.69 M(-613.2%) | -$34.73 M(+23.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | - | $12.41 M(-19.9%) | -$28.04 M(-67.9%) |
| Dec 2020 | -$87.44 M(>+9900.0%) | $15.49 M(+1361.8%) | -$87.44 M(-15.0%) |
| Sep 2020 | - | $1.06 M(-101.9%) | -$102.91 M(-1.1%) |
| Jun 2020 | - | -$57.01 M(+21.3%) | -$104.05 M(+119.5%) |
| Mar 2020 | - | -$46.98 M(<-9900.0%) | -$47.41 M(+5523.4%) |
| Dec 2019 | -$843.00 K(-75.9%) | $20.00 K(-126.3%) | -$843.00 K(-66.5%) |
| Sep 2019 | - | -$76.00 K(-79.3%) | -$2.52 M(-22.2%) |
| Jun 2019 | - | -$368.00 K(-12.2%) | -$3.24 M(-7.0%) |
| Mar 2019 | - | -$419.00 K(-74.7%) | -$3.48 M(-0.5%) |
| Dec 2018 | -$3.50 M(+211.4%) | -$1.65 M(+107.8%) | -$3.50 M(+89.6%) |
| Sep 2018 | - | -$796.00 K(+29.9%) | -$1.85 M(+75.8%) |
| Jun 2018 | - | -$613.00 K(+40.3%) | -$1.05 M(+140.3%) |
| Mar 2018 | - | -$437.00 K | -$437.00 K |
| Dec 2017 | -$1.12 M | - | - |
FAQ
- What is RAPT Therapeutics annual cash flow from investing activities?
- What is the all time high annual CFI for RAPT Therapeutics?
- What is RAPT Therapeutics annual CFI year-on-year change?
- What is RAPT Therapeutics quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for RAPT Therapeutics?
- What is RAPT Therapeutics quarterly CFI year-on-year change?
- What is RAPT Therapeutics TTM cash flow from investing activities?
- What is the all time high TTM CFI for RAPT Therapeutics?
- What is RAPT Therapeutics TTM CFI year-on-year change?
What is RAPT Therapeutics annual cash flow from investing activities?
The current annual CFI of RAPT is $104.13 M
What is the all time high annual CFI for RAPT Therapeutics?
RAPT Therapeutics all-time high annual cash flow from investing activities is $104.13 M
What is RAPT Therapeutics annual CFI year-on-year change?
Over the past year, RAPT annual cash flow from investing activities has changed by +$149.62 M (+328.91%)
What is RAPT Therapeutics quarterly cash flow from investing activities?
The current quarterly CFI of RAPT is $18.45 M
What is the all time high quarterly CFI for RAPT Therapeutics?
RAPT Therapeutics all-time high quarterly cash flow from investing activities is $32.44 M
What is RAPT Therapeutics quarterly CFI year-on-year change?
Over the past year, RAPT quarterly cash flow from investing activities has changed by -$7.30 M (-28.37%)
What is RAPT Therapeutics TTM cash flow from investing activities?
The current TTM CFI of RAPT is $74.18 M
What is the all time high TTM CFI for RAPT Therapeutics?
RAPT Therapeutics all-time high TTM cash flow from investing activities is $104.13 M
What is RAPT Therapeutics TTM CFI year-on-year change?
Over the past year, RAPT TTM cash flow from investing activities has changed by +$31.96 M (+75.69%)